Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma

Bone Marrow Transplantation

Volumn 32, Issue 6, 2003, Pages 629-631

  Tapprich, C ^a   Fenk, R ^a   Schneider, P ^a   Bernhardt, A ^a   Haas, R ^a   Kobbe, G ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Multiple myeloma; Nonmyeloablative allogeneic blood stem cell transplantation; Reduced intensity conditioning; Rheumatoid arthritis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; FLUDARABINE; GOLD; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RHEUMATOID FACTOR; STEROID;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CHIMERA; COMORBIDITY; DIZYGOTIC TWINS; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVING DONOR; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; SYNOVIORTHESIS; WHOLE BODY RADIATION;

ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 0141502369     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704183     Document Type: Article

References (15)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA: Cancer J Clin 2001; 51: 15-36.
2. Attal M, Harousseau JL, Stappa AM et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroup Francais du Myelome. N Engl J Med 1996; 335: 91-97.
3. Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793.
4. Björkstrand B, Ljungman P, Svenson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma. Blood 1988; 12: 4711-4718.
5. Munro R, Madhok R. T-cell depleted stem-cell transplantation for rheumatoid arthritis. Lancet 1998; 352: 1628-1629.
6. Slavin S, Nagler A, Varadi G, Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853-857.
7. Burt RK, Traynor A. Hematopoietic stem cell therapy of autoimmune diseases. Cur Opin Hematol 1998; 5: 472-477.
8. Mc Sweeny P. Nonmyeloablative allogeneic hematopoietic cell transplants: any role for rheumatoid arthritis? J Rheumatol 2001; 64 (Suppl.): 49-54.
9. Blade J, Samson D, Reece D et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemapoietic stem cell transplantation. Myeloma Subcommitee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998; 102: 1115-1123.
10. Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 90: 768-784.
11. Joske DJ, Ma DT, Langlands DR, Owen ET. Autologous bone-marrow transplantation for rheumatoid arthrits. Lancet 1997; 350: 337(Letter).
12. McColl G, Kohsaka H, Szer J, Wicks I. High dose chemotherapy and syngeneic hemopoetic stem cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999; 131: 507-509.
13. Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 1999; 42: 2281-2285.
14. Verburg RJ, Kruize AA, van den Hoogen FH et al. High dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 2001; 44: 754-760.
15. McKendry RJ, Huebsch L, Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup. Arthritis Rheum 1996; 39: 1246-1253.